ConductScience.org, home

Paper36088677

Highly bright aggregation-induced emission nanodots for precise photoacoustic/NIR-II fluorescence imaging-guided resection of neuroendocrine neoplasms and sentinel lymph nodes.

Xu R and 8 others. Biomaterials, 2022. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Highly bright aggregation-induced emission nanodots for precise photoacoustic/NIR-II fluorescence imaging-guided resection of neuroendocrine neoplasms and sentinel lymph nodes. Papers, record 36088677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36088677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Highly bright aggregation-induced emission nanodots for precise photoacoustic/NIR-II fluorescence imaging-guided resection of neuroendocrine neoplasms and sentinel lymph nodes.
PubMed
Journal
Biomaterials
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.45
iCite
Revised in PubMed
2022-11-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu RRuitong
2Jiao DDi
3Long QQin
4Li XXiaolin
5Shan KKe
6Kong XXianglong
7Ou HHanlin
8Ding DDan
9Tang QQiyun

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanoparticlesMajor topic
NeoplasmsMajor topic
Sentinel Lymph NodeMajor topic
Animals
Lymph Nodes
Mice
Mice, Nude
Optical Imaging

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42724657Functional matrix engineering enables aggregate-state photophysics in tumor-responsive organic NIR-II phototheranostics.Mater Today Bio2026https://conductscience.org/library/papers/42724657PubMed
42434845Nanoplatforms for Sentinel and Tumor-Draining Lymph Node Mapping: From Visualization to Pathway-Informed Staging.Adv Healthc Mater2026https://conductscience.org/library/papers/42434845PubMed
42324197[Research progress of photoacoustic imaging in diagnosis of limb lymphedema].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi2026https://conductscience.org/library/papers/42324197PubMed
42041440NIR-II AIEgens for Phototheranostics: Design, Applications and Perspectives.Biosensors (Basel)2026https://conductscience.org/library/papers/42041440PubMed
41839852Organic small-molecule NIR-II fluorophores for tumor phototheranostics.Light Sci Appl2026https://conductscience.org/library/papers/41839852PubMed
41647288Fabrication of an NIR-II fluorescence-visible indocyanine green-BioGlue for precision surgical adhesion with intraoperative leakage prevention.Regen Biomater2026https://conductscience.org/library/papers/41647288PubMed
41560815A molecular engineered NIR-II fluorescence agent with enhanced radiative and non-radiative decay for precision prostate cancer bone metastasis theranostics.Mater Today Bio2026https://conductscience.org/library/papers/41560815PubMed
41556044Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignancies.Life Med2026https://conductscience.org/library/papers/41556044PubMed
40435324Molecular Gold Nanoclusters for Advanced NIR-II Bioimaging and Therapy.Chem Rev2025https://conductscience.org/library/papers/40435324PubMed
39926710Debut of enzyme-responsive anionic cyanine for overlap-free NIR-II-to-I dual-channel tumour imaging.Chem Sci2025https://conductscience.org/library/papers/39926710PubMed
39682171Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review.Cancers (Basel)2024https://conductscience.org/library/papers/39682171PubMed
39296941The Current Status and Future Directions on Nanoparticles for Tumor Molecular Imaging.Int J Nanomedicine2024https://conductscience.org/library/papers/39296941PubMed
38858673Tumor-specific enhanced NIR-II photoacoustic imaging via photothermal and low-pH coactivated AuNR@PNIPAM-VAA nanogel.J Nanobiotechnology2024https://conductscience.org/library/papers/38858673PubMed
38738633Multimodal optoacoustic imaging: methods and contrast materials.Chem Soc Rev2024https://conductscience.org/library/papers/38738633PubMed
36846853ROS-responsive ADPH nanoparticles for image-guided surgery.Front Chem2023https://conductscience.org/library/papers/36846853PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36088677

GET https://conductscience.org/api/papers/v1/36088677/authors